Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice

Br J Nutr. 2015 Mar 28;113(6):909-22. doi: 10.1017/S0007114514004309. Epub 2015 Mar 6.

Abstract

In the present study, we investigated whether high dietary Ca and exogenous parathyroid hormone 1-34 fragments (PTH 1-34) have synergistic effects on bone formation in adult mice, and explored the related mechanisms. Adult male mice were fed a normal diet, a high-Ca diet, a PTH-treated diet, or a high-Ca diet combined with subcutaneously injected PTH 1-34 (80 μg/kg per d) for 4 weeks. Bone mineral density, trabecular bone volume, osteoblast number, alkaline phosphatase (ALP)- and type I collagen-positive areas, and the expression levels of osteoblastic bone formation-related genes and proteins were increased significantly in mice fed the high-Ca diet, the PTH-treated diet, and, even more dramatically, the high-Ca diet combined with PTH. Osteoclast number and surface and the ratio of receptor activator for nuclear factor-κB ligand (RANKL):osteoprotegerin (OPG) were decreased in the high-Ca diet treatment group, increased in the PTH treatment group, but not in the combined treatment group. Furthermore, third-passage osteoblasts were treated with high Ca (5 mM), PTH 1-34 (10⁻⁸ M) or high Ca combined with PTH 1-34. Osteoblast viability and ALP activity were increased in either the high Ca-treated or PTH-treated cultures and, even more dramatically, in the cultures treated with high Ca plus PTH, with consistent up-regulation of the expression levels of osteoblast proliferation and differentiation-related genes and proteins. These results indicate that dietary Ca and PTH play synergistic roles in promoting osteoblastic bone formation by stimulating osteoblast proliferation and differentiation.

Keywords: Bone formation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Density / drug effects
  • Bone Density Conservation Agents / pharmacology
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Resorption / metabolism
  • Bone Resorption / pathology
  • Bone Resorption / prevention & control*
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism
  • Bone and Bones / pathology
  • Calcium Channels / genetics
  • Calcium Channels / metabolism
  • Calcium, Dietary / metabolism
  • Calcium, Dietary / therapeutic use*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Combined Modality Therapy
  • Food-Drug Interactions*
  • Male
  • Mice, Inbred C57BL
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism
  • Osteoblasts / pathology
  • Osteogenesis / drug effects*
  • Parathyroid Hormone / analogs & derivatives*
  • Parathyroid Hormone / pharmacology
  • Parathyroid Hormone / therapeutic use*
  • Peptide Fragments / pharmacology
  • Peptide Fragments / therapeutic use
  • Receptors, Calcium-Sensing / agonists
  • Receptors, Calcium-Sensing / genetics
  • Receptors, Calcium-Sensing / metabolism
  • Receptors, Parathyroid Hormone / agonists
  • Receptors, Parathyroid Hormone / genetics
  • Receptors, Parathyroid Hormone / metabolism
  • TRPV Cation Channels / agonists
  • TRPV Cation Channels / genetics
  • TRPV Cation Channels / metabolism
  • Up-Regulation / drug effects

Substances

  • Bone Density Conservation Agents
  • Calcium Channels
  • Calcium, Dietary
  • Parathyroid Hormone
  • Peptide Fragments
  • Receptors, Calcium-Sensing
  • Receptors, Parathyroid Hormone
  • TRPV Cation Channels
  • Trpv6 protein, mouse